Research Catalog
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.

Selank is a synthetic heptapeptide analog of the endogenous tuftsin peptide with an added glycine-proline-lysine (Gly-Pro-Lys) sequence at the C-terminus. With the molecular formula C₄₆H₇₃N₁₃O₁₃ and a...
Lab Verified
Clinical Grade
PMID Cited
Published preclinical research has characterized the following molecular pathways and receptor interactions for Selank.
Selank binds to GABA-A receptors as an allosteric modulator, affecting receptor subunit composition and chloride channel conductance (PMID: 22786332).
Published research indicates Selank influences interleukin-6 expression and other inflammatory mediators in glial cell cultures (PMID: 22968004).
Kozlovskaya et al. (2012) characterized Selank's binding to GABA-A receptors and its allosteric modulation properties in neuronal cell cultures (PMID: 22786332).
Kozlovsky et al. (2012) investigated Selank's effects on neurotransmitter systems and cytokine expression in brain tissue models (PMID: 22968004).
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
CognitiveN/A (complex porcine peptide mixture) · Variable (low-MW neuropeptides ≤10,000 Da)
For in vitro research use only. Not for human consumption.
CognitiveC35H48N10O15 · 848.82 g/mol
For in vitro research use only. Not for human consumption.
CognitiveC14H22N4O9 · 390.35 g/mol
For in vitro research use only. Not for human consumption.